Phibro Animal Health Earnings
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$0.77
Phibro Animal Health earnings summary
Phibro Animal Health is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $0.77. In its most recent report on Aug 26, 2026 (Q4 2026), PAHC posted EPS of $0.52. Revenue for the quarter was $396.7 million.
Quarterly EPS is up 20.9% from the same quarter a year earlier. Across the last 16 reports, PAHC shares moved an average of 6.7% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
PAHC earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 26, 2026 | — | $0.52 | — | +1.5% |
| May 6, 2026 | — | $0.59 | — | -14.1% |
| Feb 4, 2026 | — | $0.67 | — | -1.5% |
| Nov 5, 2025 | — | $0.65 | — | +3.1% |
| Aug 27, 2025 | — | $0.43 | — | +6.4% |
| May 7, 2025 | — | $0.51 | — | +6.8% |
| Feb 5, 2025 | — | $0.08 | — | +8.8% |
| Nov 6, 2024 | — | $0.17 | — | +2.6% |
| Aug 28, 2024 | — | $0.02 | — | -7.3% |
| May 8, 2024 | — | $0.21 | — | +4.8% |
| Feb 7, 2024 | — | $0.03 | — | +4.3% |
| Nov 8, 2023 | — | $-0.20 | — | +13.8% |
| Aug 30, 2023 | — | $0.28 | — | -13.4% |
| May 3, 2023 | — | $0.25 | — | -4.0% |
| Feb 8, 2023 | — | $0.18 | — | +3.9% |
| Nov 9, 2022 | — | $0.10 | — | -10.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.